| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6121637 | Journal of Clinical Virology | 2012 | 4 Pages |
Abstract
Despite strong immunosuppression, the risk of HEV reactivation after stem cell transplantation appears to be very low.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Florence Abravanel, Jean-Michel Mansuy, Anne Huynh, Nassim Kamar, Laurent Alric, Jean-Marie Peron, Christian Récher, Jacques Izopet,